ATE95694T1 - Verwendung von bezafibrat zur behandlung von diabetes. - Google Patents
Verwendung von bezafibrat zur behandlung von diabetes.Info
- Publication number
- ATE95694T1 ATE95694T1 AT88113831T AT88113831T ATE95694T1 AT E95694 T1 ATE95694 T1 AT E95694T1 AT 88113831 T AT88113831 T AT 88113831T AT 88113831 T AT88113831 T AT 88113831T AT E95694 T1 ATE95694 T1 AT E95694T1
- Authority
- AT
- Austria
- Prior art keywords
- bezafibrate
- treat diabetes
- diabetes
- treat
- normolipidaemic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19873729209 DE3729209A1 (de) | 1987-09-01 | 1987-09-01 | Verwendung von bezafibrat zur behandlung von diabetes |
| EP88113831A EP0305890B1 (de) | 1987-09-01 | 1988-08-25 | Verwendung von Bezafibrat zur Behandlung von Diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE95694T1 true ATE95694T1 (de) | 1993-10-15 |
Family
ID=6334986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT88113831T ATE95694T1 (de) | 1987-09-01 | 1988-08-25 | Verwendung von bezafibrat zur behandlung von diabetes. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5304575A (es) |
| EP (1) | EP0305890B1 (es) |
| JP (1) | JP2647918B2 (es) |
| KR (1) | KR890004690A (es) |
| AT (1) | ATE95694T1 (es) |
| AU (1) | AU610228B2 (es) |
| CA (1) | CA1323575C (es) |
| DE (2) | DE3729209A1 (es) |
| DK (1) | DK472688A (es) |
| ES (1) | ES2059457T3 (es) |
| HU (1) | HU200687B (es) |
| IE (1) | IE62189B1 (es) |
| IL (1) | IL87566A0 (es) |
| PH (1) | PH24568A (es) |
| PT (1) | PT88383B (es) |
| ZA (1) | ZA886459B (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7655699B1 (en) | 1992-04-22 | 2010-02-02 | Eisai Inc. | Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors |
| US7115728B1 (en) | 1995-01-30 | 2006-10-03 | Ligand Pharmaceutical Incorporated | Human peroxisome proliferator activated receptor γ |
| TWI238064B (en) | 1995-06-20 | 2005-08-21 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
| AU4050797A (en) * | 1996-08-02 | 1998-02-25 | Ligand Pharmaceuticals Incorporated | Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators |
| AU8588798A (en) * | 1997-07-25 | 1999-02-16 | Institut Pasteur | Human peroxisome proliferator activated receptor gamma (ppargamma) gene re gulatory sequences and uses therefor |
| FR2774591B1 (fr) * | 1998-02-12 | 2000-05-05 | Lipha | Composition pharmaceutique comprenant l'association metformine et fibrate et son utilisation pour la preparation de medicaments destines a reduire l'hyperglycemie |
| WO2001051454A1 (en) * | 2000-01-13 | 2001-07-19 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| MXPA04008068A (es) | 2002-02-20 | 2004-11-26 | Lilly Co Eli | Metodo para administrar moleculas de glp-1. |
| US7264813B2 (en) * | 2003-09-24 | 2007-09-04 | Nikken Sohonsha Corporation | Therapeutic uses of Dunaliella powder |
| US20060286129A1 (en) * | 2003-12-19 | 2006-12-21 | Emisphere Technologies, Inc. | Oral GLP-1 formulations |
| CA2555316A1 (en) * | 2004-02-09 | 2005-08-18 | Aska Pharmaceutical Co., Ltd. | Combined pharmaceutical composition |
| FR2898894B1 (fr) * | 2006-03-24 | 2008-06-06 | Genfit Sa | Composes derives de n-(phenethyl)benzamide substitues, preparation et utilisations |
| US10098860B2 (en) * | 2016-07-20 | 2018-10-16 | Cipla Limited | Bezafibrate for the treatment of cancer |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2149070C3 (de) * | 1971-10-01 | 1978-03-23 | Boehringer Mannheim Gmbh, 6800 Mannheim | Phenoxyalkylcarbonsäurederivate und deren Salze, Verfahren zu deren Herstellung und Arzneimittel |
| JPS56145261A (en) * | 1980-04-10 | 1981-11-11 | Kaken Pharmaceut Co Ltd | Novel oxyacetic acid derivative, its preparation, and lowering agent of lipid in blood comprising it as active ingredient |
-
1987
- 1987-09-01 DE DE19873729209 patent/DE3729209A1/de active Granted
-
1988
- 1988-08-18 IE IE252988A patent/IE62189B1/en not_active IP Right Cessation
- 1988-08-24 DK DK472688A patent/DK472688A/da not_active Application Discontinuation
- 1988-08-25 DE DE88113831T patent/DE3884895D1/de not_active Expired - Fee Related
- 1988-08-25 EP EP88113831A patent/EP0305890B1/de not_active Expired - Lifetime
- 1988-08-25 AT AT88113831T patent/ATE95694T1/de not_active IP Right Cessation
- 1988-08-25 IL IL87566A patent/IL87566A0/xx unknown
- 1988-08-25 HU HU884456A patent/HU200687B/hu not_active IP Right Cessation
- 1988-08-25 ES ES88113831T patent/ES2059457T3/es not_active Expired - Lifetime
- 1988-08-26 AU AU21586/88A patent/AU610228B2/en not_active Ceased
- 1988-08-26 PH PH37464A patent/PH24568A/en unknown
- 1988-08-31 ZA ZA886459A patent/ZA886459B/xx unknown
- 1988-08-31 PT PT88383A patent/PT88383B/pt not_active IP Right Cessation
- 1988-08-31 CA CA000576196A patent/CA1323575C/en not_active Expired - Fee Related
- 1988-09-01 KR KR1019880011350A patent/KR890004690A/ko not_active Application Discontinuation
- 1988-09-01 JP JP63216469A patent/JP2647918B2/ja not_active Expired - Lifetime
-
1992
- 1992-12-17 US US07/993,525 patent/US5304575A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| PH24568A (en) | 1990-08-03 |
| PT88383A (pt) | 1989-07-31 |
| AU610228B2 (en) | 1991-05-16 |
| KR890004690A (ko) | 1989-05-09 |
| JP2647918B2 (ja) | 1997-08-27 |
| IE62189B1 (en) | 1994-12-28 |
| HUT47427A (en) | 1989-03-28 |
| EP0305890A2 (de) | 1989-03-08 |
| JPS6471813A (en) | 1989-03-16 |
| DK472688D0 (da) | 1988-08-24 |
| DE3729209C2 (es) | 1989-08-03 |
| DE3729209A1 (de) | 1989-03-09 |
| DK472688A (da) | 1989-03-02 |
| IE882529L (en) | 1989-03-01 |
| HU200687B (en) | 1990-08-28 |
| CA1323575C (en) | 1993-10-26 |
| ZA886459B (en) | 1989-05-30 |
| ES2059457T3 (es) | 1994-11-16 |
| AU2158688A (en) | 1989-05-25 |
| EP0305890B1 (de) | 1993-10-13 |
| EP0305890A3 (en) | 1990-08-22 |
| DE3884895D1 (de) | 1993-11-18 |
| IL87566A0 (en) | 1989-01-31 |
| PT88383B (pt) | 1992-10-30 |
| US5304575A (en) | 1994-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE88890T1 (de) | D-cycloserin und d-alanin enthaltende mischung zur verbesserung des gedaechtnisses und des lernvermoegens oder zur behandlung von kognitiven und psychotischen erkrankungen. | |
| DE3683318D1 (de) | Verwendung von alfuzosin zur behandlung von erkrankungen der harnwege. | |
| DE3878627T2 (de) | Zusammensetzung zur oberflaechenbehandlung von kautschuk. | |
| ATE95694T1 (de) | Verwendung von bezafibrat zur behandlung von diabetes. | |
| DE3788057D1 (de) | Verwendung von heterocyclischen Verbindungen zur Behandlung von Depressionen. | |
| ATE93721T1 (de) | Verwendung von fluoxetin zur behandlung des diabetes. | |
| DE3777861D1 (de) | Behandlung von gasen. | |
| ATE106736T1 (de) | Verwendung von dimethylpolysiloxan zur behandlung von erkrankungen des gastrointestinaltraktes. | |
| FI864570A0 (fi) | Terapeutiskt anvaendbar foerening. | |
| DE3854121D1 (de) | Arzneimittelzusammensetzungen zur behandlung von psoriasis. | |
| ATE45675T1 (de) | Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen. | |
| ATE25969T1 (de) | 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten. | |
| DE3787954D1 (de) | Verwendung von 5-(Subst. Phenyl)- Oxazolidinonderivaten zur Behandlung von Depressionen. | |
| DE3686688D1 (de) | Verwendung von sulfanilamido quinoxalinen zur behandlung von neoplastischen krankheiten. | |
| AT384624B (de) | Einrichtung zur gesteuerten waermebehandlung von weichenteilen | |
| ATE178336T1 (de) | Verwendung einer therapeutischen zusammensetzung zur behandlung von bronchitis | |
| DE3684825D1 (de) | Verwendung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methylsulfamoylbenzamid zur behandlung der parkinson-krankheit. | |
| ATE96667T1 (de) | Verwendung von heterocyclischen verbindungen zur behandlung von depressionen. | |
| DE3683330D1 (de) | Verwendung von imidazolinylaminoisoindolen und verwandten verbindungen zur behandlung von hyperglykaemie. | |
| ATE81001T1 (de) | Verwendung von ketonderivaten zur behandlung von bewusstseinsstoerungen. | |
| DE68906028T2 (de) | Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom. | |
| ATE66780T1 (de) | Zubereitung zur behandlung von psoriasis. | |
| ATE84435T1 (de) | Einrichtung zur behandlung von gasen. | |
| ATE5229T1 (de) | Nasenspange zur prophylaktischen oder therapeutischen behandlung von rindern. | |
| ATE64917T1 (de) | Vorrichtung zur behandlung von erntematerial. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REN | Ceased due to non-payment of the annual fee |